Scarica l'app Stockscreener
1.25
5.04%
0.06
Precedente Chiudi:
$1.19
Aprire:
$1.23
Volume 24 ore:
83,516
Relative Volume:
0.09
Capitalizzazione di mercato:
$1.68M
Reddito:
-
Utile/perdita netta:
$-11.90M
Rapporto P/E:
-0.00521
EPS:
-239.88
Flusso di cassa netto:
$-12.75M
1 W Prestazione:
-11.35%
1M Prestazione:
-23.31%
6M Prestazione:
+115.78%
1 anno Prestazione:
-87.75%
Intervallo 1D:
$1.20
$1.25
Intervallo di 1 settimana:
$1.15
$1.40
Portata 52W:
$0.1131
$22.20
Allarity Therapeutics Inc Stock (ALLR) Company Profile
Nome
Allarity Therapeutics Inc
Settore
Industria
Telefono
401-426-4664
Indirizzo
24 SCHOOL ST., 2ND FLOOR, BOSTON
Confronta ALLR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| ALLR | 1.25 | 1.68M | 0 | -11.90M | -12.75M | -239.88 |
| VRTX | 449.33 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 749.22 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 588.35 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 247.58 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 106.96 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Allarity Therapeutics Inc Borsa (ALLR) Ultime notizie
Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements - GlobeNewswire
Allarity's Phase 2 Cancer Drug Shows Promise: Patients Exceed 14-Month Treatment | ALLR Stock News - StockTitan
Allarity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Recent Operational Highlights - The Manila Times
Allarity Therapeutics Reports $18.5M Cash Position, Extended Runway in Q3 Results | ALLR Stock News - StockTitan
FINAL REMINDER ALLR DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Allarity Therapeutics, Inc. Investors to Participate in the Class Action Lawsuit! - AccessWire
DEADLINE ALERT for ALLR, and COIN: The Law Offices of Frank - GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics - Business Wire
FINAL ALLR DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Allarity Therapeutics, Inc. Investors to Join the Class Action Lawsuit! - AccessWire
ALLR DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, - GlobeNewswire
ALLR DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Allarity Therapeutics, Inc. - The Bakersfield Californian
ALLR DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Allarity Therapeutics, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ALLR - GlobeNewswire Inc.
ALLR Deadline: Rosen Law Firm Urges Allarity Therapeutics, Inc. (NASDAQ: ALLR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
ALLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Allarity Therapeutics, Inc. (ALLR) - Business Wire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics - PR Newswire
ALLR Deadline: ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit - GuruFocus.com
ALLR FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages - GlobeNewswire
ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit - cnhinews.com
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics - GlobeNewswire
ALLARITY ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Allarity Therapeutics, Inc. and Encourages Investors to Contact the Firm - ForexTV.com
ALLARITY ALERT: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire
Lawsuit filed for Investors who lost money with shares of Allarity Therapeutics, Inc. (NASDAQ: ALLR) - openPR
Glancy Prongay & Murray LLP Reminds Investors of Looming - GlobeNewswire
DEADLINE ALERT for WBTN, GTLB, ALLR, and COIN: The Law - GlobeNewswire
ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
ALLR 截止日期通知：全球領先的律師事務所 ROSEN 鼓勵 Allarity Therapeutics, Inc. 投資者在證券集體訴訟的重要截止日期 11 月 12 日 之前聘請律師 - GlobeNewswire Inc.
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allarity Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesALLR - PR Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors - GlobeNewswire
ALLR DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, - GlobeNewswire
Allr Deadline Notice: Rosen, A Global And Leading Law Firm, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important November 12 Deadline in Securities Class Action – ALLR - Wahanariau
ALLR Investors Have Opportunity to Lead Allarity Therapeutics, I - GuruFocus.com
Allarity Therapeutics stock hits 52-week low at $1.32 amid steep decline - Investing.com Australia
Allarity Therapeutics stock hits 52-week low at $1.32 amid steep decline By Investing.com - Investing.com South Africa
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
ALLR FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, - GlobeNewswire
Allarity Therapeutics, Inc. Investors: Please contact the - GlobeNewswire
ALLR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Allarity Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Allarity Therapeutics Inc Azioni (ALLR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.80%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):